Covalon Technologies Ltd. (TSXV: COV)

Market Cap	83.56M
Revenue (ttm)	31.17M
Net Income (ttm)	2.67M
Shares Out	27.40M
EPS (ttm)	0.11
PE Ratio	28.34
Forward PE	76.25
Dividend	n/a
Ex-Dividend Date	n/a

Volume	36,455
Average Volume	45,682
Open	3.060
Previous Close	3.160
Day's Range	3.000 - 3.150
52-Week Range	0.970 - 4.300
Beta	0.67
RSI	40.71
Earnings Date	Jan 27, 2025

About Covalon Technologies

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company’s platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by second...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2004
• Employees: 37
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: COV